Recruitment Partner Profile: Gisselbaek Consulting
A concise profile for recruitment companies, interim-management firms and expert-network partners matching clients with senior medical, clinical development and Medical Affairs consultants.
Consultant profile
Gisselbaek Consulting is led by Mogens Gisselbaek, MD, MSc, a senior medical leader with experience as Chief Medical Officer, Senior Medical Director in global clinical development, Medical Director and Medical Affairs leader. The company supports pharma, biotech, medtech and life science investors with fractional medical leadership, clinical development strategy, Medical Affairs, medical review and due diligence.
Best-fit assignments
- Fractional Chief Medical Officer or interim Medical Director.
- Clinical development strategy for biotech, medtech or specialty pharma.
- Medical Affairs strategy, launch readiness and operating model design.
- Investor, board or partner-facing clinical and medical due diligence.
- Senior medical and scientific review of high-stakes materials.
Therapeutic area and modality experience
Mogens brings broad senior medical and clinical development experience across pharma, biotech, medtech and specialty-care settings. His strongest experience is in rare diseases, endocrinology, haematology/rare bleeding disorders and orthopaedic medtech, with additional Medical Affairs and leadership exposure across gastroenterology, hepatology, obstetrics, oncology-adjacent care, respiratory medicine and immune-mediated conditions.
Product and evidence experience includes clinical-stage drug development from Phase I-IV, rare-disease development, growth hormone therapies, medical devices, orthopaedic biomaterials, device/drug-device combination products, post-market evidence, RWE/observational studies, investigator-initiated studies, patient-facing software and data-capture models.
Relevant client types
- Early- and mid-stage biotech companies.
- Medtech and diagnostics companies building clinical evidence.
- Specialty pharma companies needing senior medical capacity.
- Life science investors, boards and portfolio companies.
- International companies entering or expanding in Europe and the Nordic region.
Engagement models
- Fractional leadership.
- Interim executive assignment.
- Defined project or value-inflection workstream.
- Due diligence or board advisory support.
- Hour-bank or retained advisory arrangement.
Recruitment partners and intermediaries can contact Gisselbaek Consulting directly at [email protected] or through the contact page.